Announced
Synopsis
Nordic Capital and Permira, two private equity firms, withdrew their offer to acquire Bavarian Nordic, a biotechnology company that develops and manufactures vaccines, for DKK19bn.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite